Related Experiment Video
Updated: Mar 17, 2026

12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
12.9K
Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum Dots
Xiangyou Liu1, Gary B Braun1, Haizheng Zhong2
1Cancer Research Center, Sanford Burnham Prebys, Medical Discovery Institute, La Jolla, CA 92037, USA.
Summary
This study introduces cadmium-free quantum dots conjugated with tumor-targeting peptides for enhanced fluorescence imaging. These probes offer minimal toxicity and versatile multimodal imaging capabilities for precise tumor detection.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Optical Imaging
Background:
- Fluorescence imaging technologies require advanced probes.
- Quantum dots offer unique optical properties but face toxicity concerns (cadmium).
- Need for safer, effective fluorescent probes for clinical applications.
Purpose of the Study:
- To develop a versatile, cadmium-free quantum dot-based bioimaging probe.
- To conjugate CuInSe2/ZnS core/shell quantum dots with CGKRK tumor-targeting peptides.
- To evaluate the probe's performance in multimodal tumor imaging.
Main Methods:
- Synthesis of highly luminescent cadmium-free CuInSe2/ZnS core/shell quantum dots.
- Conjugation of quantum dots with CGKRK tumor-targeting peptides.
- In vivo multimodal imaging (near-infrared, time-gated, two-photon) in glioblastoma mouse models.
Main Results:
- The developed probe exhibits excellent photostability, long circulation time, and minimal toxicity.
- The probe demonstrates strong tumor-specific homing and versatile multimodal imaging capabilities.
- In glioblastoma models, the probe accurately delineated tumor boundaries and identified infiltrating cells.
Conclusions:
- Cadmium-free quantum dots conjugated with CGKRK peptides represent a promising bioimaging probe.
- The probe's versatility supports precise tumor detection and surgical guidance.
- This work supports the potential clinical translation of advanced quantum dot imaging agents.

